Fibrogen Stock Filter Stocks by Fundamentals
| FGEN Stock | USD 1.14 0.02 1.72% |
FibroGen fundamentals help investors to digest information that contributes to FibroGen's financial success or failures. It also enables traders to predict the movement of FibroGen Stock. The fundamental analysis module provides a way to measure FibroGen's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to FibroGen stock.
FibroGen | Shares Owned by Institutions |
FibroGen Institutional Holders
Institutional Holdings refers to the ownership stake in FibroGen that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of FibroGen's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing FibroGen's value.| Shares | Citadel Advisors Llc | 2023-09-30 | 1.3 M | Aqr Capital Management Llc | 2023-12-31 | 1.2 M | Morgan Stanley - Brokerage Accounts | 2023-12-31 | 816.5 K | Northern Trust Corp | 2023-12-31 | 777.4 K | Pennant Investors Lp | 2023-12-31 | 768.4 K | D. E. Shaw & Co Lp | 2023-09-30 | 724.4 K | 683 Capital Management Llc | 2023-12-31 | 700.3 K | Renaissance Technologies Corp | 2023-12-31 | 683.4 K | Millennium Management Llc | 2023-12-31 | 607.4 K | Primecap Management Company | 2023-12-31 | 14.5 M | Armistice Capital, Llc | 2023-12-31 | 9.8 M |
FibroGen Fundamentals
| Return On Equity | -10.16 | ||||
| Return On Asset | -0.36 | ||||
| Profit Margin | (1.92) % | ||||
| Operating Margin | (3.81) % | ||||
| Current Valuation | 89.44 M | ||||
| Shares Outstanding | 99.47 M | ||||
| Shares Owned By Insiders | 0.89 % | ||||
| Shares Owned By Institutions | 69.08 % | ||||
| Number Of Shares Shorted | 5.43 M | ||||
| Price To Earning | 97.67 X | ||||
| Price To Book | 53.83 X | ||||
| Price To Sales | 0.87 X | ||||
| Revenue | 147.75 M | ||||
| Gross Profit | (159.21 M) | ||||
| EBITDA | (259.28 M) | ||||
| Net Income | (284.23 M) | ||||
| Cash And Equivalents | 438.13 M | ||||
| Cash Per Share | 4.67 X | ||||
| Total Debt | 170.46 M | ||||
| Debt To Equity | 0.89 % | ||||
| Current Ratio | 2.17 X | ||||
| Book Value Per Share | (2.07) X | ||||
| Cash Flow From Operations | (315.02 M) | ||||
| Short Ratio | 2.72 X | ||||
| Earnings Per Share | (2.92) X | ||||
| Target Price | 1.75 | ||||
| Number Of Employees | 486 | ||||
| Beta | 0.74 | ||||
| Market Capitalization | 113.4 M | ||||
| Total Asset | 423.53 M | ||||
| Retained Earnings | (1.84 B) | ||||
| Working Capital | 113.89 M | ||||
| Current Asset | 200.56 M | ||||
| Current Liabilities | 67.18 M | ||||
| Net Asset | 423.53 M |
About FibroGen Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze FibroGen's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of FibroGen using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of FibroGen based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards FibroGen in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, FibroGen's short interest history, or implied volatility extrapolated from FibroGen options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out FibroGen Piotroski F Score and FibroGen Altman Z Score analysis. To learn how to invest in FibroGen Stock, please use our How to Invest in FibroGen guide.Note that the FibroGen information on this page should be used as a complementary analysis to other FibroGen's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for FibroGen Stock analysis
When running FibroGen's price analysis, check to measure FibroGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy FibroGen is operating at the current time. Most of FibroGen's value examination focuses on studying past and present price action to predict the probability of FibroGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move FibroGen's price. Additionally, you may evaluate how the addition of FibroGen to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories |
Is FibroGen's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of FibroGen. If investors know FibroGen will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about FibroGen listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.536 | Earnings Share (2.92) | Revenue Per Share 1.518 | Quarterly Revenue Growth (0.21) | Return On Assets (0.36) |
The market value of FibroGen is measured differently than its book value, which is the value of FibroGen that is recorded on the company's balance sheet. Investors also form their own opinion of FibroGen's value that differs from its market value or its book value, called intrinsic value, which is FibroGen's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because FibroGen's market value can be influenced by many factors that don't directly affect FibroGen's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between FibroGen's value and its price as these two are different measures arrived at by different means. Investors typically determine if FibroGen is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, FibroGen's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.